Viral Hepatitis

You have full text access to this OnlineOpen article

Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C†

  1. Yasuji Arase‡,*,
  2. Fumitaka Suzuki,
  3. Yoshiyuki Suzuki,
  4. Norio Akuta,
  5. Masahiro Kobayashi,
  6. Yusuke Kawamura,
  7. Hiromi Yatsuji,
  8. Hitomi Sezaki,
  9. Tetsuya Hosaka,
  10. Miharu Hirakawa,
  11. Kenji Ikeda,
  12. Hiromitsu Kumada

Article first published online: 24 OCT 2008

DOI: 10.1002/hep.22703

Issue

Hepatology

Hepatology

Volume 49, Issue 3, pages 739–744, March 2009

Additional Information

How to Cite

Arase, Y., Suzuki, F., Suzuki, Y., Akuta, N., Kobayashi, M., Kawamura, Y., Yatsuji, H., Sezaki, H., Hosaka, T., Hirakawa, M., Ikeda, K. and Kumada, H. (2009), Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C. Hepatology, 49: 739–744. doi: 10.1002/hep.22703

Author Information

  1. Department of Hepatology, Toranomon Hospital, Tokyo, Japan

  1. ‡

    fax: (81)-3-3582-7068.

*Department of Hepatology, Toranomon Hospital, 2-2-2, Toranomon, Minato-ku, Tokyo 105-8470, Japan

  1. †

    Potential conflict of interest: Nothing to report.

Publication History

  1. Issue published online: 24 FEB 2009
  2. Article first published online: 24 OCT 2008
  3. Accepted manuscript online: 24 OCT 2008 12:00AM EST
  4. Manuscript Accepted: 13 OCT 2008
  5. Manuscript Received: 25 SEP 2008

Funded by

  • Okinaka Memorial Institute for Medical Research
  • Japanese Ministry of Health, Labor, and Welfare

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (382K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Woo Jin Chung, Chronic Hepatitis C and Insulin Resistance, The Korean Journal of Gastroenterology, 2012, 59, 4, 268

    CrossRef

  2. 2
    Francesco Negro, HCV Infection and Metabolic Syndrome: Which Is the Chicken and Which Is the Egg?, Gastroenterology, 2012, 142, 6, 1288

    CrossRef

  3. 3
    Kathryn K. Stevens, Rajan K. Patel, Alan G. Jardine, HOW TO IDENTIFY AND MANAGE DIABETES MELLITUS AFTER RENAL TRANSPLANTATION, Journal of Renal Care, 2012, 38,
    Direct Link:
  4. 4
    Naoki Matsumoto, Yasuji Arase, Yuya Seko, Norihiro Imai, Yusuke Kawamura, Hitomi Sezaki, Tetsuya Hosaka, Norio Akuta, Mariko Kobayashi, Masahiro Kobayashi, Yoshiyuki Suzuki, Satoshi Saito, Fumitaka Suzuki, Kenji Ikeda, Hiromitsu Kumada, Kaoru Aida, Tetsuro Kobayashi, Prevalence and predictive factors of diabetes in hepatitis virus positive liver cirrhosis with fasting plasma glucose level of <126 mg/dL, Hepatology Research, 2012, 42, 6
    Direct Link:
  5. 5
    F. Negro, Steatosis and insulin resistance in response to treatment of chronic hepatitis C, Journal of Viral Hepatitis, 2012, 19,
    Direct Link:
  6. 6
    Elisabetta Bugianesi, Federico Salamone, Francesco Negro, The interaction of metabolic factors with HCV infection: Does it matter?, Journal of Hepatology, 2012, 56, S56

    CrossRef

  7. 7
    Chiara Giordanino, Simone Ceretto, Simona Bo, Antonina Smedile, Alessia Ciancio, Elisabetta Bugianesi, Rinaldo Pellicano, Sharmila Fagoonee, Elisabetta Versino, Giuseppe Costa, Daniele Arese, Marco Sacco, Mario Rizzetto, Giorgio Saracco, Type 2 diabetes mellitus and chronic hepatitis C: Which is worse? Results of a long-term retrospective cohort study, Digestive and Liver Disease, 2012, 44, 5, 406

    CrossRef

  8. 8
    Andres Duarte-Rojo, Elizabeth Jenny Heathcote, Jordan Jay Feld, ‘Easy to treat’ genotypes were not created equal: Can rapid virological response (RVR) level the playing field?, Journal of Hepatology, 2011, 55, 2, 466

    CrossRef

  9. 9
    A. A. Butt, F. Kanwal, Boceprevir and Telaprevir in the Management of Hepatitis C Virus-Infected Patients, Clinical Infectious Diseases, 2011, 54, 1, 96

    CrossRef

  10. 10
    Vincent Kaddai, Francesco Negro, Current understanding of insulin resistance in hepatitis C, Expert Review of Gastroenterology & Hepatology, 2011, 5, 4, 503

    CrossRef

  11. 11
    Yasuji Arase, Fumitaka Suzuki, Yusuke Kawamura, Yoshiyuki Suzuki, Masahiro Kobayashi, Naoki Matsumoto, Norio Akuta, Hitomi Sezaki, Tetsuya Hosaka, Kyoko Ogawa, Norihiro Imai, Yuya Seko, Satoshi Saito, Kenji Ikeda, Mariko Kobayashi, Hiromitsu Kumada, Development rate of chronic kidney disease in hepatitis C virus patients with advanced fibrosis after interferon therapy, Hepatology Research, 2011, 41, 10
    Direct Link:
  12. 12
    Yasuji Arase, Fumitaka Suzuki, Mariko Kobayashi, Yoshiyuki Suzuki, Yusuke Kawamura, Naoki Matsumoto, Norio Akuta, Norihisa Imai, Masahiro Kobayashi, Hitomi Sezaki, Satoshi Saito, Tetsuya Hosaka, Kenji Ikeda, Hiromitsu Kumada, Yuki Ohmoto, Kazuhisa Amakawa, Hiroshi Tsuji, Shium Dong Hsieh, Tetsurou Kobayashi, Efficacy and safety in sitagliptin therapy for diabetes complicated by chronic liver disease caused by hepatitis C virus, Hepatology Research, 2011, 41, 6
    Direct Link:
  13. 13
    Valentina Soverini, Marcello Persico, Elisabetta Bugianesi, Gabriele Forlani, Federico Salamone, Mario Massarone, Vincenzo Mura, Arianna Mazzotti, Alberto Bruno, Giulio Marchesini, HBV and HCV infection in type 2 diabetes mellitus: a survey in three diabetes units in different Italian areas, Acta Diabetologica, 2011, 48, 4, 337

    CrossRef

  14. 14
    Chao-Hung Hung, Chuan-Mo Lee, Sheng-Nan Lu, Hepatitis C virus-associated insulin resistance: pathogenic mechanisms and clinical implications, Expert Review of Anti-infective Therapy, 2011, 9, 5, 525

    CrossRef

  15. 15
    Manuel Romero-Gómez, Insulin resistance and sustained virological response in hepatitis C: from bench to bedside, Liver International, 2011, 31, 1
    Direct Link:
  16. 16
    Bong Soo Cha, Jae Hoon Moon, Management of Posttransplantation Diabetes Mellitus (PTDM), The Journal of the Korean Society for Transplantation, 2011, 25, 1, 8

    CrossRef

  17. 17
    Francesco Negro, Mechanisms of hepatitis C virus-related insulin resistance, Clinics and Research in Hepatology and Gastroenterology, 2011, 35, 5, 358

    CrossRef

  18. 18
    Luigi E Adinolfi, Luciano Restivo, Rosa Zampino, Amedeo Lonardo, Paola Loria, Metabolic alterations and chronic hepatitis C: treatment strategies, Expert Opinion on Pharmacotherapy, 2011, 12, 14, 2215

    CrossRef

  19. 19
    A. Räkel, A.D. Karelis, New-onset diabetes after transplantation: Risk factors and clinical impact, Diabetes & Metabolism, 2011, 37, 1, 1

    CrossRef

  20. 20
    Emanuele Durante-Mangoni, Domenico Iossa, Daniela Pinto, Lucia De Vincentiis, Enrico Ragone, Riccardo Utili, Safety and efficacy of peginterferon alpha plus ribavirin in patients with chronic hepatitis C and coexisting heart disease, Digestive and Liver Disease, 2011, 43, 5, 411

    CrossRef

  21. 21
    Stefan G. Hübscher, Steatosis and fibrosis progression in patients with recurrent hepatitis C infection: Complex interactions providing diagnostic and therapeutic challenges, Liver Transplantation, 2011, 17, 12
    Direct Link:
  22. 22
    B. L. Pearlman, N. Traub, Sustained Virologic Response to Antiviral Therapy for Chronic Hepatitis C Virus Infection: A Cure and So Much More, Clinical Infectious Diseases, 2011, 52, 7, 889

    CrossRef

  23. 23
    M. Eslam, T. Kawaguchi, J. A. Del Campo, M. Sata, M. Abo-Elneen Khattab, M. Romero-Gomez, Use of HOMA-IR in hepatitis C, Journal of Viral Hepatitis, 2011, 18, 10
    Direct Link:
  24. 24
    Yusuke Kawamura, Yasuji Arase, Kenji Ikeda, Miharu Hirakawa, Tetsuya Hosaka, Masahiro Kobayashi, Satoshi Saitoh, Hiromi Yatsuji, Hitomi Sezaki, Norio Akuta, Fumitaka Suzuki, Yoshiyuki Suzuki, Hiromitsu Kumada, Diabetes Enhances Hepatocarcinogenesis in Noncirrhotic, Interferon-treated Hepatitis C Patients, The American Journal of Medicine, 2010, 123, 10, 951

    CrossRef

  25. 25
    Ira M. Jacobson, Patrice Cacoub, Luigino Dal Maso, Stephen A. Harrison, Zobair M. Younossi, Manifestations of Chronic Hepatitis C Virus Infection Beyond the Liver, Clinical Gastroenterology and Hepatology, 2010, 8, 12, 1017

    CrossRef

  26. 26
    B. Kronenberger, S. Zeuzem, J. Bojunga, NASH und Hepatitis C, Der Gastroenterologe, 2010, 5, 2, 116

    CrossRef

  27. 27
    Hung-Da Tung, Jing-Houng Wang, Po-Lin Tseng, Chao-Hung Hung, Kwong-Ming Kee, Chien-Hung Chen, Kuo-Chin Chang, Chuan-Mo Lee, Chi-Sin Changchien, Yao-Der Chen, Sheng-Nan Lu, Neither Diabetes Mellitus nor Overweight Is a Risk Factor for Hepatocellular Carcinoma in a Dual HBV and HCV Endemic Area: Community Cross-Sectional and Case–Control Studies, The American Journal of Gastroenterology, 2010, 105, 3, 624

    CrossRef

  28. 28
    Yasuji Arase, Fumitaka Suzuki, Yoshiyuki Suzuki, Norio Akuta, Masahiro Kobayashi, Hitomi Sezaki, Tetsuya Hosaka, Yusuke Kawamura, Hiromi Yatsuji, Miharu Hirakawa, Kenji Ikeda, Shiun Dong Hsieh, Yuki Oomoto, Kazuhisa Amakawa, Hisahito Kato, Tamae Kazawa, Hiroshi Tsuji, Tetsuro Kobayashi, Hiromitsu Kumada, Virus clearance reduces bone fracture in postmenopausal women with osteoporosis and chronic liver disease caused by hepatitis C virus, Journal of Medical Virology, 2010, 82, 3
    Direct Link:
  29. 29
    Amedeo Lonardo, Luigi Elio Adinolfi, Salvatore Petta, Antonio Craxì, Paola Loria, Hepatitis C and diabetes: the inevitable coincidence?, Expert Review of Anti-infective Therapy, 2009, 7, 3, 293

    CrossRef

  30. 30
    Yasuji Arase, Fumitaka Suzuki, Yoshiyuki Suzuki, Norio Akuta, Masahiro Kobayashi, Yusuke Kawamura, Hiromi Yatsuji, Hitomi Sezaki, Tetsuya Hosaka, Miharu Hirakawa, Satoshi Saito, Kenji Ikeda, Mariko Kobayashi, Hiromitsu Kumada, Tetsuro Kobayashi, Losartan reduces the onset of type 2 diabetes in hypertensive Japanese patients with chronic hepatitis C , Journal of Medical Virology, 2009, 81, 9
    Direct Link:
  31. 31
    Yasuji Arase, Fumitaka Suzuki, Kenji Ikeda, Hiromitsu Kumada, Hiroshi Tsuji, Tetsuro Kobayashi, Multivariate analysis of risk factors for the development of type 2 diabetes in nonalcoholic fatty liver disease, Journal of Gastroenterology, 2009, 44, 10, 1064

    CrossRef

  32. 32
    Yasuji Arase, Reply:, Hepatology, 2009, 49, 6
    Direct Link:
  33. 33
    Tugrul Purnak, The role of effectively treated chronic hepatitis C infection in the development of type 2 diabetes mellitus, Hepatology, 2009, 49, 6
    Direct Link:
  34. 34
    Benjamin Terrier, Patrice Cacoub, Antiviral Treatment in Chronic Hepatitis C Virus Infection with Extrahepatic Manifestations,
    Direct Link:
  35. 35
    Jama M. Darling, Stanley M. Lemon, Michael W. Fried, Hepatitis C,
    Direct Link:
View Full Article (HTML) Get PDF (382K)